TJP1 and metabolic dysfunction-associated steatotic liver disease: In addition, NAFLD hepatic sEVs significantly reduced the expression of ZO-1/2 (Fig. 4D) and increased the amounts of FITC-dextran molecules across the endothelial monolayer, which was ameliorated by dynasore and MCC950 (Fig. 4E).